Company
Codagenix
Engineering viruses to transform global health.
Also known as Codagenix, Inc.
- Status
- Operatingas of 2026-09-18
- Legal name
- Codagenix, Inc.
- codagenix.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Leveraging a proprietary synthetic biology-driven approach that designs hundreds of precise, stable edits into a viral genome, Codagenix is delivering solutions for infectious disease that have all the broad immunity benefits of live-attenuated viruses combined with safety, speed and scalability.
Funding snapshot
- Total raised
- $25MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $25M2023-02-10
Funding rounds
- Round, 2023
- $25M2023-02-10, SEC form D sold, 5 investors
Loading relationship preview